SG Americas Securities’s Teva Pharmaceuticals TEVA Stock Holding History

SG Americas Securities’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-350,000	Closed	-$858K	–	3855
2020 Q1	$858K	Buy	350,000 +290,000	+483%	+$2.97M	0.01%	1403
2019 Q4	$152K	Hold	60,000	–	–	﹤0.01%	2682
2019 Q3	$330K	Sell	60,000 -254,000	-81%	-$1.95M	﹤0.01%	2104
2019 Q2	$2.37M	Sell	314,000 -75,000	-19%	-$904K	0.02%	910
2019 Q1	$859K	Sell	389,000 -971,000	-71%	-$17.1M	0.01%	1402
2018 Q4	$4.53M	Buy	1,360,000 +140,000	+11%	+$2.87M	0.04%	427
2018 Q3	$1.79M	Buy	1,220,000 +915,000	+300%	+$21.2M	0.01%	1248
2018 Q2	$109K	Sell	305,000 -235,000	-44%	-$4.79M	﹤0.01%	3015
2018 Q1	$1.39M	Sell	540,000 -177,400	-25%	-$3.46M	0.01%	1083
2017 Q4	$1.53M	Buy	717,400 +648,500	+941%	+$9.76M	0.01%	1062
2017 Q3	$517K	Sell	68,900 -56,100	-45%	-$1.26M	﹤0.01%	1820
2017 Q2	$81K	Hold	125,000	–	–	﹤0.01%	2963
2017 Q1	$199K	Buy	125,000 +21,000	+20%	+$717K	﹤0.01%	2439
2016 Q4	$920K	Sell	104,000 -150,000	-59%	-$5.99M	0.01%	1351
2016 Q3	$1.62M	Buy	254,000 +65,000	+34%	+$3.39M	0.02%	860
2016 Q2	$439K	Buy	189,000 +139,000	+278%	+$7.4M	﹤0.01%	1767
2016 Q1	$98K	Buy	+50,000	New	+$2.93M	﹤0.01%	2633
2014 Q1	–	Sell	-100,000	Closed	-$16K	–	2776
2013 Q4	$16K	Hold	100,000	–	–	﹤0.01%	2528
2013 Q3	$173K	Hold	100,000	–	–	﹤0.01%	2280
2013 Q2	$183K	Buy	+100,000	New	+$3.89M	﹤0.01%	1780

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SG Americas Securities's TEVA Position: Q1 2026 in Review

SG Americas Securities increased its Teva Pharmaceuticals (TEVA) stake by 232% in Q1 2026, buying an estimated $17.6M and bringing the position to 780,518 shares worth $23.5M. The position accounts for 0.03% of the portfolio, ranked #485.

SG Americas Securities first reported a position in TEVA in Q2 2013 and has held it in 50 quarters since. The position peaked at $53.7M in Q2 2014. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

SG Americas Securities held 780,518 shares of Teva Pharmaceuticals worth $23.5M as of Q1 2026.
SG Americas Securities bought 545,601 Teva Pharmaceuticals shares in Q1 2026, an estimated $17.6M.
Teva Pharmaceuticals made up 0.03% of SG Americas Securities's portfolio in Q1 2026, its #485 holding.
SG Americas Securities first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
SG Americas Securities's Teva Pharmaceuticals position peaked at $53.7M in Q2 2014.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.